2 not yet recruiting, 1 completed, 1 enrolling by invitation. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Not yet recruiting 2, Completed 1, Enrolling by invitation 1 |
Follow Immunosuppresion: new trials by email Literature Review of Immunosuppresion trials Research Report on Immunosuppresion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT) Prospera Immunosuppression Optimization - Kidney Transplant, Immunosuppresion | Not applicable | Not yet recruiting | Natera, Inc. | 750 | 2026-07-01 | 2026-07-22 |
| Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART) Prevention of Allosensitization - Kidney Transplant, Kidney Transplant Failure | Not applicable | Not yet recruiting | University of British Columbia | 96 | 2025-01-01 | 2025-01-31 |
| Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression Access to Shingrix dashboard - Immunosuppresion | Not applicable | Enrolling by invitation | University of California, San Francisco | 130 | 2024-09-16 | 2025-04-06 |
| Determining the Fingerprint of Endotoxin Tolerance Endotoxin (E. coli O:113, Reference Endotoxin) - Endotoxemia, Sepsis | Not applicable | Completed | Radboud University Medical Center | 110 | 2019-05-27 | 2025-02-07 |
Endotoxemia (1) · Sepsis (1)
Bacteremia (1) · Infections (1) · Inflammation (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Systemic Inflammatory Response Syndrome (1) · Toxemia (1)
Endotoxins (1) · Lipopolysaccharides (1)
Natera, Inc. (1) · Radboud University Medical Center (1) · University of British Columbia (1) · University of California, San Francisco (1)
Canada (1) · Netherlands (1) · United States (1)
I50HX003266 (1)